Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 9, 2014, Pages 849-857

  Wang, Ning ^a   Zhu, Meifen ^a   Wang, Xuanbin ^a,b   Tan, Hor Yue ^a   Tsao, Sai wah ^c   Feng, Yibin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Berberine; Hepatocellular carcinoma; MiR 23a; P53; Tumor growth inhibition

Indexed keywords

BERBERINE; HEPATOCELLULAR CARCINOMA; MIR-23A; P53; TUMOR GROWTH INHIBITION;

BERBERINE; CARCINOMA, HEPATOCELLULAR; GENE REGULATORY NETWORKS; GENES, P53; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; UP-REGULATION;

EID: 84904431496     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.05.027     Document Type: Article

References (44)

1. Yuen M.F., Hou J.L., Chutaputti A. Asia pacific working party on prevention of hepatocellular carcinoma, hepatocellular carcinoma in the Asia pacific region. J. Gastroenterol. Hepatol. 2009, 24:346-353.
2. Tang J., Feng Y., Tsao S., Wang N., Curtain R., Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009, 126:5-17.
3. Hou Q., Tang X., Liu H., Tang J., Yang Y., Jing X., Xiao Q., Wang W., Gou X., Wang Z. Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147. Cancer Sci. 2011, 102:1287-1292.
4. Wang N., Feng F., Zhu M., Tsang C.M., Man K., Tong Y., Tsao S.W. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J. Cell. Biochem. 2010, 111:1426-1436.
5. Wang G.Y., Lv Q.H., Dong Q., Xu R.Z., Dong Q.H. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J. Asian Nat. Prod. Res. 2009, 11:219-228.
6. Choi M.S., Yuk D.Y., Oh J.H., Jung H.Y., Han S.B., Moon D.C., Hong J.T. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. Anticancer Res. 2008, 28:3777-3784.
7. Choi M.S., Oh J.H., Kim S.M., Jung H.Y., Yoo H.S., Lee Y.M., Moon D.C., Han S.B., Hong J.T. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int. J. Oncol. 2009, 34:1221-1230.
8. Zhang X., Gu L., Li J., Shah N., He J., Yang L., Hu Q., Zhou M. Degradation of MDM2 by the interaction between Berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 2010, 70:9895-9904.
9. Ruvkun G. Molecular biology: glimpses of a tiny RNA world. Science 2001, 294:797-799.
10. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. miRNAs in human cancer. J. Pathol. 2011, 223:102-115.
11. Li Y., Zhu X., Gu J., Dong D., Yao J., Lin C., Huang K., Fei J. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci. 2010, 101:948-954.
12. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
13. Borel F., Konstantinova P., Jansen P.L. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 2012, 56:1371-1383.
14. Qi J., Wang J., Katayama H., Sen S., Liu S.M. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 2013, 60:135-142.
15. Wang N., Pan W., Zhu M., Zhang M., Hao X., Liang G., Feng Y. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br. J. Pharmacol. 2011, 164:731-742.
16. Wang N., Zhu M., Tsao S.W., Man K., Zhang Z., Feng Y. Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. PLoS One 2012, 7:e46318.
17. Jiang S., Zhang H.W., Lu M.H., He X.H., Li Y., Gu H., Liu M.F., Wang E.D. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010, 70:3119-3127.
18. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
19. Zhu M., Wang N., Tsao S.W., Yuen M.F., Feng Y., Wan T.S.K., Man K., Feng Y. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp. Ther. Med. 2011, 2:27-32.
20. Hermeking H. p53 enters the microRNA world. Cancer Cell 2009, 12:414-418.
21. Chen X.W., Di Y.M., Zhang J., Zhou Z.W., Li C.G., Zhou S.F. Interaction of herbal compounds with biological targets: a case study with berberine. Sci. World J. 2012, 708292.
22. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
23. Carrier F., Smith M.L., Bae I., Kilpatrick K.E., Lansing T.J., Chen C.Y., Engelstein L.M., Friend S.H., Henner W.D., Gilmed T.M., Kastanll M.B., Fornac A.J. Characterization of human Gadd45, a p53-regulated protein. J. Biol. Chem. 1994, 269:32672-32677.
24. Meng X., Dong Y., Sun Z. Mechanism of p53 downstream effectors p21 and Gadd45 in DNA damage surveillance. Sci. China Ser. C Life Sci. 1999, 42:427-434.
25. Jee H.J., Kim A.J., Song N., Kim H.J., Kim M., Koh H., Yun J. Nek6 overexpression antagonizes p53-induced senescence in human cancer cells. Cell Cycle 2010, 9:4703-4710.
26. Huang S., He X., Ding J., Liang L., Zhao Y., Zhang Z., Li J., Wan D., Gu J. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer 2008, 123:972-978.
27. Jahid S., Sun J., Edwards R.A., Dizon D., Panarelli N.C., Milsom J.W., Sikandar S.S., Gümüs Z.H., Lipkin S.M. miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov. 2012, 2:489-491.
28. Wang B., Hsu S.H., Frankel W., Ghoshal K., Jacob S.T. Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1α. Hepatology 2012, 56:186-197.
29. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
30. Rathore M.G., Saumet A., Rossi J.F., de Bettignies C., Tempe D., Lecellier C.H., Villalba M. The NF-κB member p65 controls glutamine metabolism through miR-23a. Int. J. Biochem. Cell Biol. 2012, 44:1448-1456.
31. Wrighton K.H. Small RNAs: p53 makes microRNAs mature. Nat. Rev. Cancer 2009, 9:612.
32. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010, 5:e10615.
33. Wartenberg M., Budde P., De Mareés M., Grünheck F., Tsang S.Y., Huang Y., Chen Z.Y., Hescheler J., Sauer H. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab. Investig. 2003, 83:87-98.
34. Kim J.B., Yu J.H., Ko E., Lee K.W., Song A.K., Park S.Y., Shin I., Han W., Noh D.Y. The alkaloid berberine inhibits the growth of anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010, 17:436-440.
35. Wang N., Feng Y., Lau E.P., Tsang C., Ching Y., Man K., Tong Y., Nagamatsu Y.T., Su W., Tsao S. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr. Cancer Ther. 2010, 9:354-364.
36. Tsang C.M., Lau E.P., Di K., Cheung P.Y., Hau P.M., Ching Y.P., Wong Y.C., Cheung A.L., Wan T.S., Tong Y., Tsao S.W., Feng Y. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int. J. Mol. Med. 2009, 24:131-138.
37. Piyanuch R., Sukhthankar M., Wandee G., Baek S.J. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett. 2007, 258:230-240.
38. Khan M., Giessrigl B., Vonach C., Madlener S., Prinz S., Herbaceck I., Hölzl C., Bauer S., Viola K., Mikulits W., Quereshi R.A., Knasmüller S., Grusch M., Kopp B., Krupitza G. Berberine and a Berberis lycium extract inactivate Cdc25A and induce alpha-tubulin acetylation that correlate with HL-60 cell cycle inhibition and apoptosis. Mutat. Res. 2010, 683:123-130.
39. Katiyar S.K., Meeran S.M., Katiyar N., Akhtar S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol. Carcinog. 2009, 48:24-37.
40. Liu Z., Liu Q., Xu B., Wu J., Guo C., Zhu F., Yang Q., Gao G., Gong Y., Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat. Res. 2009, 662:75-83.
41. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 2012, 12:613-626.
42. Jeon Y.J., Lee K.Y., Cho Y.Y., Pugliese A., Kim H.G., Jeong C.H., Bode A.M., Dong Z. Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells. J. Biol. Chem. 2010, 285:28126-28133.
43. Nassirpour R., Shao L., Flanagan P., Abrams T., Jallal B., Smeal T., Yin M.J. Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target. Mol. Cancer Res. 2010, 8:717-728.
44. Jee H.J., Kim H.J., Kim A.J., Song N., Kim M., Yun J. Nek6 suppresses the premature senescence of human cancer cells induced by camptothecin and doxorubicin treatment. Biochem. Biophys. Res. Commun. 2011, 408:669-673.